Skip to main content
Neuland Labs

Main navigation

  • CDMO Services
    • Small Molecules
    • Peptides
  • Generic APIs
    • API Products
    • Download Brochure
  • Our Capabilities
    • Chemistry & Reactions
    • Peptide Technologies
    • Lifecycle Management (Phase-Appropriate Development)
    • Quality & Regulatory Compliance
    • Technology Transfer
    • Analytical Expertise
    • Process Safety & Engineering
  • Contact us
User account menu
  • Log in
By admin, 29 September, 2026

Neuland Investor Presentation Q4 FY26

Investor Presentations
2025-26
PDF
NLL_Q4FY26_InvestorPresentationvF.pdf (2.29 MB)
By admin, 29 September, 2026

Neuland Investor Presentation Q1 FY27

Investor Presentations
2026-27
PDF
Neuland-Laboratories-Q1FY27-Investor-Presentation-vF.pdf (2.31 MB)
By admin, 29 September, 2026

Signed SE Intimation Trading Window Closure Q2FY27

Board Meeting
2026-27
PDF
SE-Intimation_Closure-of-Trading-Window-28-9-2026.pdf (416.39 KB)
By admin, 25 September, 2026

Glossary: Drug Master File (DMF)

By admin, 25 September, 2026

Glossary: DOE (Design of Experiment)

By admin, 24 September, 2026

Glossary: Complex Peptides

By admin, 24 September, 2026

Glossary: CMC (Chemistry, Manufacturing and Controls)

By admin, 24 September, 2026

Glossary: Contract Manufacturing Organization (CMO)

By admin, 24 September, 2026

Glossary: cGMP (Current Good Manufacturing Practice)

By admin, 24 September, 2026

Glossary: Bulk Drug Substance

Pagination

  • First page
  • Previous page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page
  • Last page
RSS feed
Powered by Drupal